Exact Mass: 266.0411

Exact Mass Matches: 266.0411

Found 62 metabolites which its exact mass value is equals to given mass value 266.0411, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4,4'-Methylenebis(2-chloroaniline)

4-[(4-amino-3-chlorophenyl)methyl]-2-chloroaniline

C13H12Cl2N2 (266.0377)


KEIO_ID M142

   

2-O-p-Coumaroyltartronic acid

2-{[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}propanedioic acid

C12H10O7 (266.0427)


2-O-p-Coumaroyltartronic acid is found in pulses. 2-O-p-Coumaroyltartronic acid is a constituent of Vigna radiata (mung bean). Constituent of Vigna radiata (mung bean). 2-O-p-Coumaroyltartronic acid is found in pulses.

   

4-[3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid

4-[3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid

C12H11ClN2O3 (266.0458)


   

Echinochrome A

6-ethyl-2,3,5,7,8-pentahydroxy-1,4-dihydronaphthalene-1,4-dione

C12H10O7 (266.0427)


   

N,N'-Dichloro-N,N'-diphenylmethanediamine

N-chloro-N-{[chloro(phenyl)amino]methyl}aniline

C13H12Cl2N2 (266.0377)


   

Kynapcin-13

Kynapcin-13

C12H10O7 (266.0427)


   
   

Maybridge1_006099

Maybridge1_006099

C11H10N2O4S (266.0361)


   
   
   
   

5,6,7,8-Tetrahydroxy-2-(1-hydroxy-aethyl)-[1,4]naphthochinon|5,6,7,8-tetrahydroxy-2-(1-hydroxy-ethyl)-[1,4]naphthoquinone

5,6,7,8-Tetrahydroxy-2-(1-hydroxy-aethyl)-[1,4]naphthochinon|5,6,7,8-tetrahydroxy-2-(1-hydroxy-ethyl)-[1,4]naphthoquinone

C12H10O7 (266.0427)


   

coniochaetone H

coniochaetone H

C13H11ClO4 (266.0346)


   

5-Bromo-N,N-dimethyltryptamine

5-Bromo-N,N-dimethyltryptamine

C12H15BrN2 (266.0419)


   

7-chloro-4-methyl-2-oxochromen-6-yl propanoate

7-chloro-4-methyl-2-oxochromen-6-yl propanoate

C13H11ClO4 (266.0346)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.100 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101

   

5-Hydroxysulfadiazine

5-Hydroxysulfadiazine

C10H10N4O3S (266.0474)


   

2-O-p-Coumaroyltartronic acid

2-{[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}propanedioic acid

C12H10O7 (266.0427)


   

8-Quinolinesulfonic acid,5-acetamido- (4CI)

8-Quinolinesulfonic acid,5-acetamido- (4CI)

C11H10N2O4S (266.0361)


   

4-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid

4-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid

C12H11ClN2O3 (266.0458)


   

Orpanoxin

Orpanoxin

C13H11ClO4 (266.0346)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

(QUINOLINE-8-SULFONYLAMINO)-ACETIC ACID

(QUINOLINE-8-SULFONYLAMINO)-ACETIC ACID

C11H10N2O4S (266.0361)


   

4-(3-CHLOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC ACID

4-(3-CHLOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC ACID

C12H11ClN2O3 (266.0458)


   

2-(4-BROMOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE

2-(4-BROMOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C12H15BrN2 (266.0419)


   

ETHYL 2-(METHYLTHIO)-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBOXYLATE

ETHYL 2-(METHYLTHIO)-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBOXYLATE

C9H9F3N2O2S (266.0337)


   

magnesium dibenzoate

magnesium dibenzoate

C14H10MgO4 (266.043)


   

6-Bromo-2,3,4,4a,9,9a-hexahydro-1H-carbazol-1-amine

6-Bromo-2,3,4,4a,9,9a-hexahydro-1H-carbazol-1-amine

C12H15BrN2 (266.0419)


   

2-(5-bromo-1H-indol-3-yl)-N,N-dimethylethanamine

2-(5-bromo-1H-indol-3-yl)-N,N-dimethylethanamine

C12H15BrN2 (266.0419)


   

1-Tosyl-1H-imidazole-4-carboxylic acid

1-Tosyl-1H-imidazole-4-carboxylic acid

C11H10N2O4S (266.0361)


   

{[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetic acid

{[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetic acid

C11H10N2O4S (266.0361)


   

6-Bromo-3-ethyl-1-isopropyl-1H-indazole

6-Bromo-3-ethyl-1-isopropyl-1H-indazole

C12H15BrN2 (266.0419)


   

pentafluorobenzyl methacrylate

pentafluorobenzyl methacrylate

C11H7F5O2 (266.0366)


   

CYCLOPROPANECARBOXAMIDE, 1-AMINO-N-(CYCLOPROPYLSULFONYL)-2-ETHENYL-, HYDROCHLORIDE (1R,2S)-

CYCLOPROPANECARBOXAMIDE, 1-AMINO-N-(CYCLOPROPYLSULFONYL)-2-ETHENYL-, HYDROCHLORIDE (1R,2S)-

C9H15ClN2O3S (266.0492)


   

4-Cyclopropyl-2-methanesulfonyl-6-trifluoromethyl-pyrimidine

4-Cyclopropyl-2-methanesulfonyl-6-trifluoromethyl-pyrimidine

C9H9F3N2O2S (266.0337)


   

Pemirolast potassium

Pemirolast potassium

C10H7KN6O (266.0318)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Pemirolast potassium (TWT-8152) is a histamine H1 antagonist and mast cell stabilizer that acts as an antiallergic agent. Target: Histamine H1 Receptor Pemirolast potassium (TWT-8152) is a new oral, nonbronchodilator antiallergy medication that is being evaluated for the therapy of asthma [1]. Pemirolast potassium (TWT-8152) inhibits chemical mediator release from tissue mast cells and is also shown to inhibit the release of peptides including substance P, Pemirolast potassium (TWT-8152) reduces kaolin intake by inhibition of substance P release in rats [2]. Pemirolast potassium (TWT-8152) potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats [3]. Pemirolast potassium (TWT-8152) potassium is used for the treatment of allergic conjunctivitis and prophylaxis for pulmonary hypersensitivity reactions to drugs such as paclitaxel [4].

   

(4-(4-CHLORO-2-FLUOROPHENOXY)PHENYL)BORONIC ACID

(4-(4-CHLORO-2-FLUOROPHENOXY)PHENYL)BORONIC ACID

C12H9BClFO3 (266.0317)


   

10-bromo-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

10-bromo-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

C12H15BrN2 (266.0419)


   

ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate

ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate

C12H11ClN2O3 (266.0458)


   

hydroxyoctyloxostannane

hydroxyoctyloxostannane

C8H18O2Sn (266.0329)


   

Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone

Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone

C14H6N2O4 (266.0328)


   

2-piperidin-4-ylsulfanylpyridine,dihydrochloride

2-piperidin-4-ylsulfanylpyridine,dihydrochloride

C10H16Cl2N2S (266.0411)


   

3-chloro-2-morpholinyl-5-trifluoromethylpyridine

3-chloro-2-morpholinyl-5-trifluoromethylpyridine

C10H10ClF3N2O (266.0434)


   

(S)-1-(3-Chloro-5-trifluoroMethyl-pyridin-2-yl)-pyrrolidin-3-ol

(S)-1-(3-Chloro-5-trifluoroMethyl-pyridin-2-yl)-pyrrolidin-3-ol

C10H10ClF3N2O (266.0434)


   

Methanesulfonic acid, 1,1,1-trifluoro-, 2,2-diethoxyethyl ester

Methanesulfonic acid, 1,1,1-trifluoro-, 2,2-diethoxyethyl ester

C7H13F3O5S (266.0436)


   

Potassium Benzilate

Potassium Benzilate

C14H11KO3 (266.0345)


   

1H-Purine-2,6-diamine sulfate (2:1) monohydrate

1H-Purine-2,6-diamine sulfate (2:1) monohydrate

C5H10N6O5S (266.0433)


   

1,2,3,4-TETRAHYDRO-6-METHYL-4-(4-CHLOROPHENYL)-2-OXO-5-PYRIMIDINECARBOXYLIC ACID

1,2,3,4-TETRAHYDRO-6-METHYL-4-(4-CHLOROPHENYL)-2-OXO-5-PYRIMIDINECARBOXYLIC ACID

C12H11ClN2O3 (266.0458)


   

Sulfadiazine hydroxylamine

Sulfadiazine hydroxylamine

C10H10N4O3S (266.0474)


A pyrimidine having a 4-hydroxyaminobenzenesulfonamido group at the 2-position.

   

2-(3-Methyl-2,4-dioxo-thiazolidin-5-ylamino)-benzoic acid

2-(3-Methyl-2,4-dioxo-thiazolidin-5-ylamino)-benzoic acid

C11H10N2O4S (266.0361)


   

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 7-chloro-4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 7-chloro-4-oxo-, ethyl ester

C12H11ClN2O3 (266.0458)


   

(7R)-6-Formyl-7-(1-methyl-1H-1,2,3-triazol-4-YL)-4,7-dihydro-1,4-thiazepine-3-carboxylic acid

(7R)-6-Formyl-7-(1-methyl-1H-1,2,3-triazol-4-YL)-4,7-dihydro-1,4-thiazepine-3-carboxylic acid

C10H10N4O3S (266.0474)


   

7-Ethyl-3,4,5,6,8-pentahydroxynaphthalene-1,2-dione

7-Ethyl-3,4,5,6,8-pentahydroxynaphthalene-1,2-dione

C12H10O7 (266.0427)


   

phenazine-1,6-dicarboxylate

phenazine-1,6-dicarboxylate

C14H6N2O4-2 (266.0328)


   

phenazine-1,6-dicarboxylate

phenazine-1,6-dicarboxylate

C14H6N2O4 (266.0328)


A dicarboxylic acid dianion obtained by deprotonation of the carboxy groups of phenazine-1,6-dicarboxylic acid; major species at pH 7.3.

   

Methylenebis(chloroaniline)

4,4-methylene-bis-(2-chloroaniline)

C13H12Cl2N2 (266.0377)


   

4,4-methylene-bis-(2-chloroaniline)

4,4-methylene-bis-(2-chloroaniline)

C13H12Cl2N2 (266.0377)


A chloroaniline that consists of two 2-chloroaniline units joined by a methylene bridge.

   

2,3-dimethyl 5,6-dihydroxy-1-benzofuran-2,3-dicarboxylate

2,3-dimethyl 5,6-dihydroxy-1-benzofuran-2,3-dicarboxylate

C12H10O7 (266.0427)


   
   

2-hydroxy-2-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]propanedioic acid

2-hydroxy-2-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]propanedioic acid

C12H10O7 (266.0427)


   

6-ethyl-1,4,5,7,8-pentahydroxynaphthalene-2,3-dione

6-ethyl-1,4,5,7,8-pentahydroxynaphthalene-2,3-dione

C12H10O7 (266.0427)


   

hydroxy(8-hydroxy-6-methoxy-1-oxoisochromen-4-yl)acetic acid

hydroxy(8-hydroxy-6-methoxy-1-oxoisochromen-4-yl)acetic acid

C12H10O7 (266.0427)


   

(r)-hydroxy(8-hydroxy-6-methoxy-1-oxoisochromen-4-yl)acetic acid

(r)-hydroxy(8-hydroxy-6-methoxy-1-oxoisochromen-4-yl)acetic acid

C12H10O7 (266.0427)


   

5-(3,4,5-trihydroxyphenoxy)benzene-1,2,3-triol

5-(3,4,5-trihydroxyphenoxy)benzene-1,2,3-triol

C12H10O7 (266.0427)